|
Volumn 56, Issue 6, 1998, Pages 1039-1044
|
Telmisartan
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMLODIPINE;
ANGIOTENSIN RECEPTOR;
ATENOLOL;
LISINOPRIL;
LOSARTAN POTASSIUM;
TELMISARTAN;
WARFARIN;
AMBULATORY MONITORING;
AREA UNDER THE CURVE;
ARTICLE;
BLOOD PRESSURE MONITORING;
BLOOD PRESSURE REGULATION;
CLINICAL TRIAL;
DIASTOLIC BLOOD PRESSURE;
DOSE RESPONSE;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG EXCRETION;
DRUG TOLERABILITY;
FATIGUE;
GLOMERULOSCLEROSIS;
HEADACHE;
HEART VENTRICLE HYPERTROPHY;
HUMAN;
HYPERTENSION;
IMPOTENCE;
INTRAVENOUS DRUG ADMINISTRATION;
META ANALYSIS;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
RECEPTOR BLOCKING;
SYSTOLIC BLOOD PRESSURE;
VERTIGO;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANIMALS;
ANTIHYPERTENSIVE AGENTS;
BENZIMIDAZOLES;
BENZOATES;
BIOTRANSFORMATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
HALF-LIFE;
HUMANS;
HYPERTENSION;
INTESTINAL ABSORPTION;
RECEPTORS, ANGIOTENSIN;
|
EID: 0032420068
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.2165/00003495-199856060-00007 Document Type: Article |
Times cited : (118)
|
References (22)
|